Evidence map›Paper›PMID 35130954›Full record

ArticleGenome biology2022

Single-cell isoform analysis in human immune cells.

Roger Volden, Christopher Vollmers

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. The circadian isoform landscape of mouse livers.NAR genomics and bioinformatics · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Long-read RNA sequencing: A transformative technology for exploring transcriptome complexity in human diseases.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Roger VoldenDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, CA, 95064, USA.
Christopher VollmersDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, CA, 95064, USA. vollmers@ucsc.edu.ORCID 0000-0002-7626-6222
University of California, Santa Cruz · US

Funding

Realizing the potential of long-read sequencing technologyR35GM133569 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Christopher Vollmers · 2019 to 2026
$3.4M
UC Santa Cruz Training Program In Genomic SciencesT32HG008345 · NHGRI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI BROOKS, ANGELA NORIE, GREEN, RICHARD EDWARD · 2015 to 2020
$1.4M
NHGRI NIH HHS T32 HG008345NIGMS NIH HHS R35 GM133569
6 · The paper itself

Abstract

High-throughput single-cell analysis today is facilitated by protocols like the 10X Genomics platform or Drop-Seq which generate cDNA pools in which the origin of a transcript is encoded at its 5' or 3' end. Here, we used R2C2 to sequence and demultiplex 12 million full-length cDNA molecules generated by the 10X Genomics platform from ~3000 peripheral blood mononuclear cells. We use these reads, independent from Illumina data, to identify B cell, T cell, and monocyte clusters and generate isoform-level transcriptomes for cells and cell types. Finally, we extract paired adaptive immune receptor sequences unique to each T and B cell.

Indexed as

Leukocytes, MononuclearSingle-Cell AnalysisGene Expression ProfilingHigh-Throughput Nucleotide SequencingHumansProtein IsoformsSequence Analysis, RNAProtein Isoforms

Identifiers

PMID35130954
PMCPMC8819920
OpenAlexW4210882759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.